nodes	percent_of_prediction	percent_of_DWPC	metapath
Cetirizine—Rhinitis seasonal—Metformin—polycystic ovary syndrome	0.103	0.138	CcSEcCtD
Cetirizine—Fungal infection—Metformin—polycystic ovary syndrome	0.029	0.039	CcSEcCtD
Cetirizine—Rigors—Metformin—polycystic ovary syndrome	0.0274	0.0369	CcSEcCtD
Cetirizine—Accidental injury—Metformin—polycystic ovary syndrome	0.0253	0.0341	CcSEcCtD
Cetirizine—Ear pain—Metformin—polycystic ovary syndrome	0.0191	0.0257	CcSEcCtD
Cetirizine—Injury—Metformin—polycystic ovary syndrome	0.0177	0.0238	CcSEcCtD
Cetirizine—Migraine—Metformin—polycystic ovary syndrome	0.016	0.0215	CcSEcCtD
Cetirizine—Dehydration—Metformin—polycystic ovary syndrome	0.0151	0.0204	CcSEcCtD
Cetirizine—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.0145	0.0196	CcSEcCtD
Cetirizine—Abdominal distension—Metformin—polycystic ovary syndrome	0.0142	0.019	CcSEcCtD
Cetirizine—Sweating increased—Metformin—polycystic ovary syndrome	0.0137	0.0184	CcSEcCtD
Cetirizine—Loperamide—POMC—polycystic ovary syndrome	0.0133	0.186	CrCbGaD
Cetirizine—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.0131	0.0176	CcSEcCtD
Cetirizine—Rhinitis—Metformin—polycystic ovary syndrome	0.0113	0.0152	CcSEcCtD
Cetirizine—Hepatitis—Metformin—polycystic ovary syndrome	0.0113	0.0151	CcSEcCtD
Cetirizine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.0112	0.0151	CcSEcCtD
Cetirizine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0111	0.0149	CcSEcCtD
Cetirizine—Eye disorder—Metformin—polycystic ovary syndrome	0.0105	0.0141	CcSEcCtD
Cetirizine—Flushing—Metformin—polycystic ovary syndrome	0.0104	0.0141	CcSEcCtD
Cetirizine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.0104	0.0141	CcSEcCtD
Cetirizine—Nefazodone—ADRA1B—polycystic ovary syndrome	0.0103	0.145	CrCbGaD
Cetirizine—Immune system disorder—Metformin—polycystic ovary syndrome	0.0102	0.0137	CcSEcCtD
Cetirizine—HRH1—Monoamine GPCRs—ADRA1D—polycystic ovary syndrome	0.0102	0.0548	CbGpPWpGaD
Cetirizine—Chills—Metformin—polycystic ovary syndrome	0.0101	0.0136	CcSEcCtD
Cetirizine—HRH1—Monoamine GPCRs—ADRA1B—polycystic ovary syndrome	0.00989	0.0533	CbGpPWpGaD
Cetirizine—Flatulence—Metformin—polycystic ovary syndrome	0.00965	0.013	CcSEcCtD
Cetirizine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00959	0.0129	CcSEcCtD
Cetirizine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00942	0.0127	CcSEcCtD
Cetirizine—Vision blurred—Metformin—polycystic ovary syndrome	0.00923	0.0124	CcSEcCtD
Cetirizine—Tremor—Metformin—polycystic ovary syndrome	0.00918	0.0123	CcSEcCtD
Cetirizine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00909	0.0122	CcSEcCtD
Cetirizine—Malaise—Metformin—polycystic ovary syndrome	0.00883	0.0119	CcSEcCtD
Cetirizine—Syncope—Metformin—polycystic ovary syndrome	0.00879	0.0118	CcSEcCtD
Cetirizine—Palpitations—Metformin—polycystic ovary syndrome	0.00866	0.0116	CcSEcCtD
Cetirizine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00861	0.0116	CcSEcCtD
Cetirizine—HRH1—Amine ligand-binding receptors—ADRA1D—polycystic ovary syndrome	0.00854	0.0461	CbGpPWpGaD
Cetirizine—Hypertension—Metformin—polycystic ovary syndrome	0.00846	0.0114	CcSEcCtD
Cetirizine—Chest pain—Metformin—polycystic ovary syndrome	0.00834	0.0112	CcSEcCtD
Cetirizine—Myalgia—Metformin—polycystic ovary syndrome	0.00834	0.0112	CcSEcCtD
Cetirizine—HRH1—Amine ligand-binding receptors—ADRA1B—polycystic ovary syndrome	0.00831	0.0448	CbGpPWpGaD
Cetirizine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00828	0.0111	CcSEcCtD
Cetirizine—Discomfort—Metformin—polycystic ovary syndrome	0.00824	0.0111	CcSEcCtD
Cetirizine—Oedema—Metformin—polycystic ovary syndrome	0.008	0.0108	CcSEcCtD
Cetirizine—Infection—Metformin—polycystic ovary syndrome	0.00794	0.0107	CcSEcCtD
Cetirizine—Shock—Metformin—polycystic ovary syndrome	0.00787	0.0106	CcSEcCtD
Cetirizine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00784	0.0105	CcSEcCtD
Cetirizine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00783	0.0105	CcSEcCtD
Cetirizine—Skin disorder—Metformin—polycystic ovary syndrome	0.00777	0.0104	CcSEcCtD
Cetirizine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00773	0.0104	CcSEcCtD
Cetirizine—Anorexia—Metformin—polycystic ovary syndrome	0.00762	0.0103	CcSEcCtD
Cetirizine—HRH1—Monoamine GPCRs—ADRA1A—polycystic ovary syndrome	0.00749	0.0404	CbGpPWpGaD
Cetirizine—Hypotension—Metformin—polycystic ovary syndrome	0.00747	0.0101	CcSEcCtD
Cetirizine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00728	0.0098	CcSEcCtD
Cetirizine—HRH1—Monoamine GPCRs—ADRB3—polycystic ovary syndrome	0.00721	0.0389	CbGpPWpGaD
Cetirizine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00718	0.00966	CcSEcCtD
Cetirizine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00713	0.00959	CcSEcCtD
Cetirizine—Somnolence—Metformin—polycystic ovary syndrome	0.00711	0.00956	CcSEcCtD
Cetirizine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00704	0.00947	CcSEcCtD
Cetirizine—Quetiapine—ADRA1D—polycystic ovary syndrome	0.00703	0.0987	CrCbGaD
Cetirizine—Zuclopenthixol—ADRA1A—polycystic ovary syndrome	0.00699	0.0982	CrCbGaD
Cetirizine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00695	0.00935	CcSEcCtD
Cetirizine—Nefazodone—ADRA1A—polycystic ovary syndrome	0.00695	0.0976	CrCbGaD
Cetirizine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.0069	0.00929	CcSEcCtD
Cetirizine—Fatigue—Metformin—polycystic ovary syndrome	0.00689	0.00927	CcSEcCtD
Cetirizine—Constipation—Metformin—polycystic ovary syndrome	0.00684	0.0092	CcSEcCtD
Cetirizine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00659	0.00886	CcSEcCtD
Cetirizine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00654	0.0088	CcSEcCtD
Cetirizine—Trazodone—ADRA1A—polycystic ovary syndrome	0.00643	0.0903	CrCbGaD
Cetirizine—Urticaria—Metformin—polycystic ovary syndrome	0.00635	0.00855	CcSEcCtD
Cetirizine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00632	0.0085	CcSEcCtD
Cetirizine—HRH1—Amine ligand-binding receptors—ADRA1A—polycystic ovary syndrome	0.0063	0.034	CbGpPWpGaD
Cetirizine—HRH1—Amine ligand-binding receptors—ADRB3—polycystic ovary syndrome	0.00606	0.0327	CbGpPWpGaD
Cetirizine—Quetiapine—ADRA1B—polycystic ovary syndrome	0.006	0.0842	CrCbGaD
Cetirizine—Asthenia—Metformin—polycystic ovary syndrome	0.00574	0.00772	CcSEcCtD
Cetirizine—Pruritus—Metformin—polycystic ovary syndrome	0.00566	0.00761	CcSEcCtD
Cetirizine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00547	0.00736	CcSEcCtD
Cetirizine—Dizziness—Metformin—polycystic ovary syndrome	0.00529	0.00711	CcSEcCtD
Cetirizine—Vomiting—Metformin—polycystic ovary syndrome	0.00508	0.00684	CcSEcCtD
Cetirizine—Rash—Metformin—polycystic ovary syndrome	0.00504	0.00678	CcSEcCtD
Cetirizine—Dermatitis—Metformin—polycystic ovary syndrome	0.00504	0.00678	CcSEcCtD
Cetirizine—Headache—Metformin—polycystic ovary syndrome	0.00501	0.00674	CcSEcCtD
Cetirizine—Nausea—Metformin—polycystic ovary syndrome	0.00475	0.00639	CcSEcCtD
Cetirizine—Quetiapine—ADRA1A—polycystic ovary syndrome	0.00404	0.0567	CrCbGaD
Cetirizine—HRH1—Monoamine GPCRs—ADRB2—polycystic ovary syndrome	0.00389	0.021	CbGpPWpGaD
Cetirizine—Flunarizine—CYP1A1—polycystic ovary syndrome	0.00387	0.0543	CrCbGaD
Cetirizine—HRH1—Amine ligand-binding receptors—ADRB2—polycystic ovary syndrome	0.00327	0.0176	CbGpPWpGaD
Cetirizine—Haloperidol—CYP1A1—polycystic ovary syndrome	0.00325	0.0457	CrCbGaD
Cetirizine—Cinnarizine—CYP1A1—polycystic ovary syndrome	0.00306	0.0429	CrCbGaD
Cetirizine—HRH1—G alpha (q) signalling events—PTAFR—polycystic ovary syndrome	0.00261	0.0141	CbGpPWpGaD
Cetirizine—HRH1—G alpha (q) signalling events—ADRA1D—polycystic ovary syndrome	0.00254	0.0137	CbGpPWpGaD
Cetirizine—HRH1—G alpha (q) signalling events—ADRA1B—polycystic ovary syndrome	0.00247	0.0133	CbGpPWpGaD
Cetirizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PTAFR—polycystic ovary syndrome	0.00234	0.0126	CbGpPWpGaD
Cetirizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1D—polycystic ovary syndrome	0.00227	0.0122	CbGpPWpGaD
Cetirizine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.00222	0.012	CbGpPWpGaD
Cetirizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1B—polycystic ovary syndrome	0.00221	0.0119	CbGpPWpGaD
Cetirizine—HRH1—GPCRs, Class A Rhodopsin-like—LHCGR—polycystic ovary syndrome	0.00216	0.0116	CbGpPWpGaD
Cetirizine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER3—polycystic ovary syndrome	0.00216	0.0116	CbGpPWpGaD
Cetirizine—HRH1—GPCRs, Class A Rhodopsin-like—PTAFR—polycystic ovary syndrome	0.00202	0.0109	CbGpPWpGaD
Cetirizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.00196	0.0106	CbGpPWpGaD
Cetirizine—HRH1—IL-4 Signaling Pathway—IRS2—polycystic ovary syndrome	0.00195	0.0105	CbGpPWpGaD
Cetirizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.00191	0.0103	CbGpPWpGaD
Cetirizine—HRH1—G alpha (q) signalling events—ADRA1A—polycystic ovary syndrome	0.00187	0.0101	CbGpPWpGaD
Cetirizine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.00185	0.00998	CbGpPWpGaD
Cetirizine—HRH1—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.00185	0.00998	CbGpPWpGaD
Cetirizine—HRH1—G alpha (q) signalling events—GNRH1—polycystic ovary syndrome	0.00174	0.00938	CbGpPWpGaD
Cetirizine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.00173	0.00933	CbGpPWpGaD
Cetirizine—HRH1—IL-4 Signaling Pathway—IRS1—polycystic ovary syndrome	0.0017	0.00918	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00169	0.0091	CbGpPWpGaD
Cetirizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00168	0.00906	CbGpPWpGaD
Cetirizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1A—polycystic ovary syndrome	0.00167	0.00902	CbGpPWpGaD
Cetirizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00163	0.00881	CbGpPWpGaD
Cetirizine—HRH1—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00158	0.00852	CbGpPWpGaD
Cetirizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—polycystic ovary syndrome	0.00156	0.00838	CbGpPWpGaD
Cetirizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00145	0.0078	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00141	0.0076	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00141	0.0076	CbGpPWpGaD
Cetirizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00139	0.0075	CbGpPWpGaD
Cetirizine—HRH1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00135	0.0073	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00132	0.00711	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00128	0.0069	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00124	0.00671	CbGpPWpGaD
Cetirizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00124	0.00668	CbGpPWpGaD
Cetirizine—HRH1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00123	0.00663	CbGpPWpGaD
Cetirizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00119	0.00643	CbGpPWpGaD
Cetirizine—HRH1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00118	0.00635	CbGpPWpGaD
Cetirizine—HRH1—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.00117	0.00633	CbGpPWpGaD
Cetirizine—HRH1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00115	0.00621	CbGpPWpGaD
Cetirizine—HRH1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00105	0.00568	CbGpPWpGaD
Cetirizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.00105	0.00566	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00103	0.00556	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000954	0.00514	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000943	0.00509	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000908	0.0049	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000897	0.00484	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000877	0.00473	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000866	0.00467	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000863	0.00465	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000845	0.00455	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000845	0.00455	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000841	0.00453	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000802	0.00432	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000796	0.00429	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000796	0.00429	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000784	0.00422	CbGpPWpGaD
Cetirizine—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000778	0.00419	CbGpPWpGaD
Cetirizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000752	0.00405	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000745	0.00402	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000723	0.0039	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000723	0.0039	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000723	0.0039	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000703	0.00379	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000676	0.00365	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000657	0.00354	CbGpPWpGaD
Cetirizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000644	0.00347	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00064	0.00345	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000639	0.00344	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000592	0.00319	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000586	0.00316	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000583	0.00314	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000581	0.00313	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000533	0.00287	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000529	0.00285	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000513	0.00277	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000512	0.00276	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000507	0.00273	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000496	0.00267	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00049	0.00264	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000484	0.00261	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000475	0.00256	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000466	0.00251	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000463	0.0025	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00046	0.00248	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000455	0.00245	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000453	0.00244	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00045	0.00243	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000431	0.00233	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000427	0.0023	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000427	0.0023	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000412	0.00222	CbGpPWpGaD
Cetirizine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000402	0.00217	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.0004	0.00215	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000388	0.00209	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000377	0.00203	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000368	0.00198	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000343	0.00185	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000335	0.0018	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000313	0.00169	CbGpPWpGaD
Cetirizine—HRH1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000306	0.00165	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000304	0.00164	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000294	0.00158	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000286	0.00154	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—FST—polycystic ovary syndrome	0.000279	0.0015	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000277	0.00149	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000275	0.00148	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000272	0.00147	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000266	0.00143	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000257	0.00139	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000257	0.00139	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000255	0.00137	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000252	0.00136	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000243	0.00131	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000239	0.00129	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000237	0.00128	CbGpPWpGaD
Cetirizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000236	0.00127	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000233	0.00126	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000221	0.00119	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000218	0.00118	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000209	0.00112	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000198	0.00107	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000195	0.00105	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000193	0.00104	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00018	0.000968	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00018	0.000968	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000173	0.000933	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000171	0.000924	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000167	0.000901	CbGpPWpGaD
Cetirizine—HRH1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000166	0.000897	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000158	0.000852	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000157	0.000847	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000157	0.000845	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000151	0.000814	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000149	0.000801	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000138	0.000743	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000131	0.000708	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000129	0.000695	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00011	0.000595	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000108	0.000582	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	9.64e-05	0.00052	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	9.28e-05	0.0005	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	9.23e-05	0.000498	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	8.93e-05	0.000481	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	8.92e-05	0.000481	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.48e-05	0.000457	CbGpPWpGaD
Cetirizine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	6.83e-05	0.000368	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.83e-05	0.000314	CbGpPWpGaD
Cetirizine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	4.03e-05	0.000217	CbGpPWpGaD
